PharmTech | Webcast

Event Overview:
Process development and procurement questions aren’t addressed in the current product-development paradigm until it’s too late. By the time process developers, quality assurance professionals, and procurement specialists are brought into product development, they may find themselves saddled with inefficient synthetic pathways and difficult-to-procure materials. Speakers Jennifer Miller, Executive Director of Global R&D at Pfizer, and Hedley Rees, Managing Director at Biotech PharmaFlow, discuss new strategies for streamlining product development and realizing greater efficiencies by realigning functions in pharmaceutical product development.

What You Will Learn :
»	Why R&D in the pharma industry operates in isolation from later development considerations

»	Opportunities to address supply-chain issues earlier in product development and so avoid costly mistakes late in the process

»	New ways of thinking and new skill sets required to make your firm’s approach to product development more manufacturing-friendly and cost efficient

»	How changing your drug-development process may result in more regulatory compliance and faster approval times

»	How to build greater flexibility into your firm’s drug development plan

Who Should Attend:
»	Pharmaceutical R&D staff and managers

»	Pre-Clinical Development

»	Clinical Development

»	Regulatory Affairs

»	Quality Assurance

»	Chemistry, Manufacturing and Controls (CMC)

»	Finance

»	Marketing

»	Informatics and Information Systems

»	Business Development

»	Licensing

»	General Management

»	Procurement

»	Supply Management

»	Operations

»	Production Management

»	Inventory Management & Control

»	Production & Material Planning

»	Demand Planning

»	Logistics

What you will receive:

»	60 Minute Presentation	»	Free Recording of the Presentation

»	Speaker PowerPoint Presentation		Register now for only $299 an individual